1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Cytomegalovirus reactivation in pediatric patients after allogeneic hematopoietic cell transplant
    Meeting Abstract

    Camacho-Bydume, C.; Rodriguez-Sanchez, M. I.; Papanicolaou, G.; Prockop, S.; Klein, E.; Cancio, M.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Outpatient step-down management of low-risk pediatric patients with fever and neutropenia
    Meeting Abstract

    Bailey, K.; Camacho-Bydume, C.; Fassel, H.; Kinnaman, M.; Massey, A.; Smith, M.; Seo, S.; Wexler, L.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Are we improving erectile function recovery after radical prostatectomy? Analysis of patients treated over the last decade
    Meeting Abstract

    Capogrosso, P.; Vertosick, E. A.; Benfante, N. E.; Eastham, J. A.; Scardino, P. J.; Vickers, A. J.; Mulhall, J. P.
    Journal of Sexual Medicine (2019)

    Fulltext@MSK | Save
  • Exosomal basigin (CD147, EMMPRIN) promotes tumor progression via immunomodulation
    Meeting Abstract

    Bailey, K.; Hatano, M.; Di Giannatale, A.; Hoshino, A.; Bui, J.; Molina, H.; Lyden, D.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Plasma cell-free DNA for noninvasive molecular diagnostics in Wilms tumor patients
    Meeting Abstract

    Kothari, P.; Ortiz, M.; Yang, J.; Gedvilaite, E.; Enriquez, J.; Shukla, N.; Tsui, D.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) plus olaratumab versus dox plus PBO in patients (pts) with advanced soft tissue sarcomas (STS)
    Meeting Abstract

    Tap, W. D.; Wagner, A. J.; Papai, Z.; Ganjoo, K. N.; Yen, C. C.; Schoffski, P.; Razak, A. R. A.; Broto, J. M.; Spira, A. I.; Kawai, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
    Meeting Abstract

    Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Mercade, T. M.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save